Genetic testing can gauge prostate cancer risk
Five genetic variants and a family history accounted for almost half (46 percent) of prostate cancer patients. Researchers identified five genetic locations associated with risk of developing prostate cancer: three on chromosome 8q24, one on chromosome 17q12 and one on 17q24.3. – Genetic testing of DNA in a blood sample can determine which men are likely to develop prostate cancer, as five genetic variants previously associated with prostate cancer risk have a strong cumulative effect.